Forecasting cardiovascular risk reduction with semaglutide in overweight and obese with heart disease: a nationwide cohort study.
Mats Christian Højbjerg LassenKristoffer Grundtvig SkaarupMuthiah VaduganathanJohn W OstrominskiJens Ulrik Stæhr JensenTor Biering-SorensenNiklas Dyrby JohansenPublished in: European journal of preventive cardiology (2024)
Keyphrases